Fragile Treg is thought to have anti-tumor activity owing to its decreased expression of immunosuppressive factors such as interleukin 10 (IL-10) and its ability to secrete interferon-γ (IFN-γ) [37,38]. The gene discussed is IFNG; the disease is neoplasm.